Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan for Prevention of NSAID-Induced Ulcer Recurrence
NCT01568385Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan in gastric ulcer, duodenal ulcer, sponsored by Takeda. Started Apr 2012; status: completed.
02
Drugs
vonoprazan
03
Conditions
gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on NCT01568385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01568385.